Ultragenyx Pharmaceutical Inc. buy Stifel Nicolaus
Start price
31.05.24
/
50%
€37.00
Target price
31.05.25
€116.79
Performance (%)
-20.00%
End price
01.06.25
€29.60
Summary
This prediction ended on 01.06.25 with a price of €29.60. The price of Ultragenyx Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.00%. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.970% | 2.970% | -52.074% |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% |
Comments by Stifel_Nicolaus for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Stifel Nicolaus from $124.00 to $127.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten